AR016920A1 - FORMULATION OF 8A-AZALIDES USEFUL FOR THE TREATMENT OR PREVENTION OF AN ENERGY OR BACTERIAL RESPIRATORY INFECTION - Google Patents

FORMULATION OF 8A-AZALIDES USEFUL FOR THE TREATMENT OR PREVENTION OF AN ENERGY OR BACTERIAL RESPIRATORY INFECTION

Info

Publication number
AR016920A1
AR016920A1 ARP980104488A ARP980104488A AR016920A1 AR 016920 A1 AR016920 A1 AR 016920A1 AR P980104488 A ARP980104488 A AR P980104488A AR P980104488 A ARP980104488 A AR P980104488A AR 016920 A1 AR016920 A1 AR 016920A1
Authority
AR
Argentina
Prior art keywords
prevention
treatment
useful
azalides
formulation
Prior art date
Application number
ARP980104488A
Other languages
Spanish (es)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806029.6A external-priority patent/GB9806029D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AR016920A1 publication Critical patent/AR016920A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de una 8a-azalida para la preparacion de un medicamento util para el tratamiento o prevencion de una infeccion entérica o respiratoria bacteriana, quecomprende una cantidad terapéutica o profilácticamente efectiva de dicha 8a-azalida y al menosu n vehículo apropiado.Use of an 8a-azalide for the preparation of a medicament useful for the treatment or prevention of an enteric or respiratory bacterial infection, comprising a therapeutic or prophylactically effective amount of said 8a-azalide and at least an appropriate vehicle.

ARP980104488A 1997-09-10 1998-09-09 FORMULATION OF 8A-AZALIDES USEFUL FOR THE TREATMENT OR PREVENTION OF AN ENERGY OR BACTERIAL RESPIRATORY INFECTION AR016920A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5832997P 1997-09-10 1997-09-10
GBGB9806029.6A GB9806029D0 (en) 1998-03-20 1998-03-20 8a-Azalides as veterinary antimicrobial agents

Publications (1)

Publication Number Publication Date
AR016920A1 true AR016920A1 (en) 2001-08-01

Family

ID=46203437

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104488A AR016920A1 (en) 1997-09-10 1998-09-09 FORMULATION OF 8A-AZALIDES USEFUL FOR THE TREATMENT OR PREVENTION OF AN ENERGY OR BACTERIAL RESPIRATORY INFECTION

Country Status (9)

Country Link
KR (1) KR100426510B1 (en)
AR (1) AR016920A1 (en)
BE (1) BE2012C011I2 (en)
BG (1) BG64765B1 (en)
CY (2) CY1112647T1 (en)
FR (1) FR12C0022I2 (en)
HR (1) HRP20000140A2 (en)
LU (1) LU91963I2 (en)
NO (1) NO312746B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions

Also Published As

Publication number Publication date
KR20010023822A (en) 2001-03-26
HRP20000140A2 (en) 2000-12-31
CY2012008I2 (en) 2016-04-13
FR12C0022I2 (en) 2013-11-01
LU91963I2 (en) 2012-05-29
NO20001231D0 (en) 2000-03-09
LU91963I9 (en) 2019-01-02
BG104235A (en) 2000-11-30
CY1112647T1 (en) 2016-02-10
CY2012008I1 (en) 2016-04-13
BE2012C011I2 (en) 2018-02-05
FR12C0022I1 (en) 2012-04-27
NO312746B1 (en) 2002-07-01
BG64765B1 (en) 2006-03-31
KR100426510B1 (en) 2004-04-13
NO20001231L (en) 2000-05-08

Similar Documents

Publication Publication Date Title
CO4290346A1 (en) Azithromycin Controlled Release Dosage Forms
EE9700192A (en) Oral pharmaceutical dosage form comprising a proton pump inhibitor and an antacid or alginate
UA56989C2 (en) PHYSIOLOGICALLY ACTIVE PEG-CONJUGATE OF a-INTERFERON, A METHOD FOR PREPARING THE SAME, A PHARMACEUTICAL COMPOSITION BASED THEREON AND A METHOD FOR TREATMENT OR PROPHYLAXIS OF IMMUNOMODULAR DISEASES
BR0111195A (en) Use of b-1,2'-deoxy-nucleosides in the treatment of hepatitis delta virus infection
AR016798A1 (en) USE OF A LACTOBACILLUS CEPA FOR THE PREPARATION OF A MEDICINAL PRODUCT
TR199903053T2 (en) Benzimidazole trevleri.
NO20004282D0 (en) Matrix protein preparations for wound healing
BR9811298A (en) Use of a physiologically acceptable vanadium compound
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
WO2000012049A3 (en) A method for the treatment of staphylococcal disease
NO990440L (en) Preparation that includes mupirocin and chlorhexidine
EP0869801A4 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
WO2000030435A3 (en) Foulbrood treatments
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
WO1999051256A3 (en) Use of l-glu-l-trp in the treatment of hiv infection
ES2194104T3 (en) USE OF SELEGYLINE FOR THE TREATMENT OF LOSS OF HEARING IN MAMMALS.
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
GB0028130D0 (en) Polypeptide and uses thereof
EE03514B1 (en) A combination of compounds for the treatment of HIV infection or AIDS, its use and a pharmaceutical composition
EE200300213A (en) Use of SARP-1 for the treatment and / or prevention of scleroderma
AU3401093A (en) Therapeutic agent for threatened abortion
AR016920A1 (en) FORMULATION OF 8A-AZALIDES USEFUL FOR THE TREATMENT OR PREVENTION OF AN ENERGY OR BACTERIAL RESPIRATORY INFECTION
NZ512850A (en) Treatment of papillomavirus infections
PT1052991E (en) USING LOPERAMID FOR THE TREATMENT OF MICROBIAL INFECTIONS
MD980129A (en) Antiherpetic remedy

Legal Events

Date Code Title Description
FC Refusal